Sobegapharma SRL
0.8 FTEThe score of Sobegapharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +23 % Total assets +9 % Headcount (avg FTE) +60 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sobegapharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 24,247 € | ||||
| Equity | 187,268 € | ||||
| Cash | 108,495 € | ||||
| EBITDA | 143,571 € | ||||
| Total assets | €1.04m |
Filed annual accounts
- Year ended 30 Jun 2025filed on 01 Feb 2026
- Year ended 30 Jun 2024filed on 17 Feb 2025
- Year ended 30 Jun 2023filed on 14 Feb 2024
- Year ended 30 Jun 2022filed on 28 Feb 2023
- Year ended 30 Jun 2021filed on 03 Feb 2022
Sobegapharma's financial analysis
- Solvency18.1%sector median: 38.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sobegapharma
Sobegapharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0898.114.684
- VAT number
- BE0898114684
- Peppol
- Registered · 0208:0898114684 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 May 2008
- Registered office
- 7000 Mons
- Size
- Micro · 0.8 FTE
- Latest accounts
- 2025 · filed on 01 Feb 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Sobegapharma (SRL) has been based in Mons since 2008, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 24,247 € and equity of 187,268 €; its revenue is not published. With 0.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 18.1%, below the median of its sector (38.7%).
Companies similar to Sobegapharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Van Damme C. Retail sale of pharmaceutical products Veurne · balance sheet €1.30m
- Pharmacie DU Petit Champ Retail sale of pharmaceutical products Pont-à-Celles · balance sheet €1.07m
- JM Pharma Care Retail sale of pharmaceutical products Andenne · balance sheet 878,696 €
- Niali Retail sale of pharmaceutical products Mechelen · balance sheet €1.41m
- De Zorgapotheek Retail sale of pharmaceutical products Hulshout · balance sheet €1.19m
- Pharmakaiser Grivegnee Retail sale of pharmaceutical products Liège · balance sheet €1.21m
- Penta Apotheek Retail sale of pharmaceutical products Kortrijk · balance sheet 360,148 €
- Braeckevelt-Lafaut Retail sale of pharmaceutical products Bruges · balance sheet €2.44m
Frequently asked questions about Sobegapharma
What is the revenue of Sobegapharma?
Sobegapharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sobegapharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0898114684 for Sobegapharma, if the company is VAT-registered. Its company number (CBE) is 0898.114.684.
Where is the registered office of Sobegapharma?
According to the CBE register, the registered office of Sobegapharma is in 7000 Mons.
What is the equity of Sobegapharma?
At the close of the 2025 financial year, the equity of Sobegapharma amounts to 187,268 €, a solvency of 18.1% of total assets.
How many people work at Sobegapharma?
0.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Sobegapharma?
The register lists 1 active mandates at Sobegapharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sobegapharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →